OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - AMGEN | Market Closed - Deutsche Boerse AG 20:37:12 28/05/2024 BST | ||
| 7.84 EUR | -7.11% |
|
| Current month | +36.35% | ||
| 1 month | +47.37% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 28/05/24 | 7.84 | -7.11% |
| 27/05/24 | 8.44 | -0.12% |
| 24/05/24 | 8.45 | -0.82% |
| 23/05/24 | 8.52 | -4.16% |
| 22/05/24 | 8.89 | -3.89% |
Delayed Quote Deutsche Boerse AG
Last update May 28, 2024 at 08:37 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB0ZNK |
| ISIN | DE000SB0ZNK5 |
| Date issued | 08/06/2020 |
| Strike | 214.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.72 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.82 € |
|---|---|
| Lowest since issue | 1.16 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
300.2
USD
Average target price
316.3
USD
Spread / Average Target
+5.36%
- Stock Market
- Certificates
- Certificat
